OpenAI co-founder says he feared Musk would ‘physically attack’ him

OpenAI co-founder Greg Brockman testified that Elon Musk threatened to withhold funding and became visibly angry during a 2017 meeting over control and equity in a proposed for-profit arm, underscoring governance tensions at the center of the trial. The case could affect OpenAI’s restructuring and leadership, with Musk seeking remedies that would bar Altman and Brockman from working at the company. The article also highlights OpenAI’s evolution from a charity-founded startup to a capped-profit structure and nonprofit foundation ownership stake of 26%.

Analysis

The market-relevant signal is not the courtroom theater; it is the growing probability that OpenAI’s governance ultimately gets priced as a control-risk asset rather than a pure growth story. Even if the legal merits are noisy, the testimony reinforces a narrative that the company’s capital structure and decision rights were improvised under stress, which raises the discount rate for any private-market valuation tied to future financing events. That matters most for late-stage AI peers: if investors demand clearer governance and cleaner IP/control rights, capital may shift toward firms with simpler cap tables and fewer founder disputes.

For TSLA, the direct P&L impact is de minimis, but the second-order effect is reputational and strategic. Any evidence that Musk is distracted by legacy battles or that his AI credibility is being questioned in public weakens the premium attached to xAI/Tesla AI optionality and could slow the market’s willingness to underwrite a unified AI narrative across his ecosystem. This is a months-long overhang rather than a days-long trade, but it can matter if Tesla’s stock starts trading more like a bundled holding company for Musk execution risk.

The contrarian point is that litigation can also crystallize value by forcing transparency on ownership and governance; if the process ends with a cleaner structure, the AI franchise could re-rate higher. Near term, the key catalyst is the judge’s and jury’s reception to the governance record, not the emotional testimony. Any sign that remedies could constrain management or alter restructuring economics would hit private-market comps first, then spill into public AI multiples via sentiment and funding-spread expansion.

Key Decisions for Investors

• Maintain a tactical short bias on TSLA into headline-heavy trial days, but size it as a governance/sentiment trade rather than a fundamentals short; use 2-6 week horizons and cover into any settlement or judge-led narrowing of remedies.
• Own downside protection on AI private-market proxies with expensive governance narratives; favor put spreads on listed AI beneficiaries or secondary-market exposure if accessible, targeting a 1:3 premium-to-max-loss profile over the next 1-3 months.
• Pair trade: long simpler, capital-light AI infrastructure beneficiaries vs short governance-complex AI platform names, expressing a preference for cleaner cap tables and lower legal overhang over branded model franchises.
• If TSLA implied volatility compresses after a trial headline, consider selling near-dated calls against equity or replacing stock with call spreads; the edge is in monetizing elevated event premium rather than betting on outright collapse.
• Watch for any court language that threatens restructuring or executive restrictions; that would be the trigger to add to the short side for 1-2 weeks, as private-market repricing would likely lead public-name multiple compression.